Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study-Reference-Cited by-同舟云学术

Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study

Published:2022-04 Issue:2 Volume:7 Page:100466
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Sinn K.,Mosleh B.,Steindl A.,Zoechbauer-Mueller S.,Dieckmann K.,Widder J.,Steiner E.,Klepetko W.,Hoetzenecker K.,Laszlo V.,Doeme B.,Klikovits T.,Hoda M.A.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference32 articles.

1. The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM Classification for lung cancer;Goldstraw;J Thorac Oncol,2016

2. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming 8th edition of the TNM Classification for lung cancer;Asamura;J Thorac Oncol,2015

3. 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer;Eberhardt;Ann Oncol,2015

4. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial;Albain;Lancet (Lond, Engl),2009

5. Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer;Thomas;Lancet Oncol,2008

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survivorship program including long‐term toxicities and quality‐of‐life development over 10 years in a randomized trial in operable stage III non‐small‐cell lung cancer (ESPATUE);International Journal of Cancer;2024-08-28

2. Chest wall resections for non-small cell lung cancer: a literature review;Journal of Thoracic Disease;2024-07

3. Efficiency and safety of neoadjuvant PD-1 inhibitor (sintilimab) combined with chemotherapy in potentially resectable stage IIIA/IIIB non-small cell lung cancer: Neo-Pre-IC, a single-arm phase 2 trial;eClinicalMedicine;2024-02

4. NEOADJUVANT CHEMORADIOTHERAPY IN THE MULTIMODALITY TREATMENT OF STAGE IIIA(N2) NON-SMALL CELL LUNG CANCER (NSCLC);Oncology;2024

5. Survivorship Program Including Long-Term Toxicities and Quality-of-Life Development Over Ten Years within a Randomized Phase-III Trial in Operable Stage III Non-Small-Cell Lung Cancer (ESPATUE);2023-12-11